Breaking minutes ago - Congress overrides president's veto
Breaking minutes ago - Congress overrides president's veto of Sept. 11 legislation
WASHINGTON (AP) — Congress voted overwhelmingly Wednesday to allow families of Sept. 11 victims to sue Saudi Arabia for its alleged backing of the attackers, handing Barack Obama the first veto override of his presidency.
Both the House and Senate voted decisively to reverse Obama's decision to scuttle the legislation. Democrats in both chambers abandoned the president in large numbers despite warnings from Obama and top national security officials that flaws in the bill could put U.S. interests, troops, and intelligence personnel at risk.
The Senate vote was 97-1. The House vote a few hours later was 348-77.
Lawmakers said their priority was the 9/11 victims and their families, not Saudi Arabia.
"The White House and the executive branch (are) far more interested in diplomatic considerations," said Sen. Chuck Schumer, D-N.Y., a sponsor of the bill. "We're more interested in the families and in justice."
Speaking at a forum in Washington, CIA Director John Brennan said he was concerned about how Saudi Arabia, a key U.S. ally in the Middle East, would interpret the bill. He said the Saudis provide significant amounts of information to the U.S. to help foil extremist plots.
"It would an absolute shame if this legislation, in any way, influenced the Saudi willingness to continue to be among our best counterterrorism partners," Brennan said.
Brennan, who said he visited lawmakers Wednesday to argue against an override of Obama's veto, noted that there is a tremendous amount of Saudi investment in the United States. "Do they want to leave them here so they could potentially be attached by some type of court ruling that is going to award the litigants?" he asked.
After senators acted, White House spokesman Josh Earnest called the vote the "single most embarrassing thing" the Senate has done in decades and "an abdication" of its responsibility. He accused members of the Senate Judiciary Committee of not understanding the legislation and its impact on the military.
Five weeks before state and national elections, lawmakers refused to oppose a measure strongly supported by 9/11 families who say they are still seeking justice 15 years after attackers killed nearly 3,000 people. Saudi Arabia, an important U.S. ally in the Middle East, is staunchly opposed to the measure.
Despite reversing Obama's decision, a group of senators acknowledged that defects in the bill could open a legal Pandora's box, triggering lawsuits from people in other countries seeking redress for injuries or deaths caused by military actions in which the U.S. may have had a role.
In a letter sent Tuesday to Senate Minority Leader Harry Reid, Obama said the bill would erode sovereign immunity principles that prevent foreign litigants "from second-guessing our counterterrorism operations and other actions that we take every day."
But proponents of the bill dismissed Obama's concerns as unpersuasive. Sen. John Cornyn of Texas, the Senate's No. 2 Republican, and other supporters said the bill is narrowly tailored and applies only to acts of terrorism that occur on U.S. soil.
"This bill is about respecting the voices and rights of American victims," Cornyn said.
Families of the victims and their attorneys dismissed concerns over the legislation as fearmongering.
Sen. Ben Cardin of Maryland, one of the Democrats who broke with Obama and voted to override, said, "The risks of shielding the perpetrators of terrorism from justice are greater than the risks this legislation may pose to America's presence around the world."
The legislation gives victims' families the right to sue in U.S. court for any role that elements of the Saudi government may have played in the 2001 attacks. Fifteen of the 19 Sept. 11 hijackers were Saudis. Courts would be permitted to waive a claim of foreign sovereign immunity when an act of terrorism occurred inside U.S. borders, according to the terms of the bill.
A group of national-security minded legislators pledged to discuss how to repair problem areas during the upcoming lame-duck session of Congress. But the fact that legislation could pass both chambers of Congress without closer scrutiny left at least a few senators chiding themselves for not examining its ramifications more closely.
The Justice Against Sponsors of Terrorism Act, or JASTA, moved to the floor of the Senate in May and was passed by voice vote. The bill cleared the House earlier this month, also by voice vote.
"We didn't pay much attention to this," said Sen. Dianne Feinstein of California, the top Democrat on the Senate intelligence committee. "And boy is that ever a lesson learned."
Obama vetoed the measure last week, telling lawmakers the bill would make the U.S. vulnerable to retaliatory litigation.
In his letter to Reid, the president said other countries could attempt to use JASTA to justify similar immunity exceptions to target U.S. policies and activities that they oppose.
In a separate letter sent Monday to a senior House member, Defense Secretary Ash Carter described the potential for foreign litigants to seek classified intelligence data and analysis and sensitive operational information to establish their cases in what could be an "intrusive discovery process."
Missing the vote were Sens. Bernie Sanders, I-Vt., and Tim Kaine, D-Va.
1
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Pew Pew: Lasers Are the Future of Defense Forget lightsabers, we've got something even flashier—a market that's going to double in worth by 2035. High-energy laser weapons are coming in hot, growing from USD 2.17 billion in 2026 to an estimated USD 4.54 billion by the end of 2035. That's no small potatoes! What's Driving This Beam Dream? The military is all about upping...
Continue Reading
Third Quarter Results: Crunching the Numbers Every season brings new tidbits, and when XPLR Infrastructure, LP (NYSE: XIFR) dropped their third-quarter 2026 results, you bet I was ready with my magnifying glass. November 3rd was the day to circle on your calendars, as the folks over at Juno Beach sure had something to say. They’ve plastered the details across their...
Continue Reading
How often do you hear about a country stepping confidently into the tech realm with its own set of silicon-built security? This is exactly what's happening with Vietnam's ambitious leap with the VGC v1.0 chip, rolled out by the nation's Government Cipher Committee and Viettel Group. Hitting a level of speed that blows past the sluggish pace of software-only methods, this...
Continue Reading
A Solid Quarter for CVS Health CVS Health Corporation has once again turned heads with its third-quarter 2026 results. When you're pulling $108.4 billion in quarterly revenue, up 5.4% from last year, folks notice. Adjusted earnings hit $2.09 per share, climbing a respectable 30% from $1.60 the year before. The cherry on top? A big fat boost in 2026 guidance, signaling...
Continue Reading
Rethinking How Research Data Drives Discovery When researchers generate truckloads of data, finding patterns that lead to breakthroughs often becomes a game of hide and seek. It's like having a jumbo puzzle with pieces scattered all over the place. Enter the NIH Common Fund Data Ecosystem—a game changer attempting to glue together these pieces across the research...
Continue Reading
In a world where medical advancements keep shifting gears, BRIJ Medical just pulled a fast one by closing a $5 million financing round—outpacing their original $3 million target. What drove this sudden increase? Well, it's simple. Their existing investors spotted an opportunity too ripe to pass up, proving yet again, money talks when confidence backs it up. Expanding...
Continue Reading
AI and Radiology: A Match Made for Mount Sinai Today, we're diving into a technological leap that promises to shake up the healthcare sector—Sectra's integration of artificial intelligence with radiology at Mount Sinai Health System. The deal pairs Sectra's prowess in medical imaging IT and cybersecurity with the healthcare giant in New York, aiming to redefine how...
Continue Reading
Resource Expansion at the Shaakichiuwaanaan Property You ever see a resource report that makes you do a double take? That's the vibe here with PMET's game-changing update on their Shaakichiuwaanaan property in Quebec. They've crunched the numbers at the Helios Caesium Zone and CV4 Pegmatite, and the results? A juicy increase in the grade, scale, and tonnage across three...
Continue Reading
Fractal’s Revenue Moment: Climbing New Peaks Fractal Analytics just knocked it out of the park, folks. Imagine this—an AI company pulling in $100 million for the first quarter, getting a 20% jump in revenue year on year. That's right, these numbers aren't just fancy figures; they're staggering proof that Fractal's hitting its AI stride. The healthcare and life...
Continue Reading
The 2027 Shanghai Boat Show: A Decades-Spanning Legacy You ever catch the wave just right, feeling that rush when the tide’s in your favor? That’s the buzz around the 2027 China (Shanghai) International Boat Show—better known as CIBS—celebrating its 30th anniversary. In this boat show shindig, we're looking at a whole host of innovations that could power up this...
Continue Reading
Top 5 Most Recently Viewed Articles
Investors Face Challenges Following Business Misrepresentation NEW YORK — Agilon Health, Inc. (NYSE: AGL) has come under scrutiny lately due to serious allegations regarding the accuracy of its business disclosures. The investigation aims to support shareholders who may have suffered significant financial losses related to these issues. Understanding the Situation...
Continue Reading
Understanding the Class Action Against Neumora Therapeutics In the realm of biopharmaceutical investments, changes can occur rapidly. Recently, news broke about a class action involving Neumora Therapeutics, Inc. (NASDAQ: NMRA), stirring concerns among shareholders. This case, centered around allegations against the company's Initial Public Offering (IPO) documents, sheds...
Continue Reading
Mary Beth Kingston's Impact on Healthcare Technology Kontakt.io, a leader in healthcare Real-Time Location Systems (RTLS) and digital transformation, has welcomed Mary Beth Kingston to its Healthcare Advisory Board. With a remarkable career spanning over 40 years, Kingston is a notable advocate for nurse safety and wellbeing. Her expertise will be instrumental in...
Continue Reading
An Overview of Legal Developments for Liquidia Corporation Liquidia Corporation (NASDAQ: LQDA), a prominent biopharmaceutical company specializing in innovative therapies for rare cardiopulmonary diseases, is facing new legal challenges. Recently, they encountered litigation filed by United Therapeutics. This development highlights ongoing tensions within the pulmonary...
Continue Reading
Microsoft's Significant Breach: Overview The cybersecurity landscape has seen a seismic shift due to a major flaw in Microsoft Corporation's MSFT SharePoint servers. This issue has adversely affected more than 400 organizations across the globe, marking it as one of the most significant cybersecurity incidents of recent times. Understanding the Scope Eye Security, a Dutch...
Continue Reading